1. Graziani L, Silvestro A, Bertone V et al. Vascular involvement in diabetic subjects with ischemic foot ulcer: a new morphologic categorization of disease severity. Eur J Vasc Endovasc Surg 2007; 33: 453–60.
2. Drueke T. Arterial intima and media calcification: distinct entities with different pathogenesis or all the same? Clin J Am Soc Nephrol 2008; 3: 1583–4.
3. Jude E, Oyibo S, Chalmers N et al. Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome. Diabetes Care 2001; 24: 1433–7.
4. Peregrin J, Koznar B, Kovac J. PTA of infrapopliteal arteries: long-term clinical follow-up and analysis of factors influencing clinical outcome. Cardiovasc Intervent Radiol 2010; 33: 720–5.
5. Neville R, Attinger C, Bulan E et al. Revascularization of a specific angiosome for limb salvage: does the target artery matter? Ann Vasc Surg 2009; 23: 367–73.
6. Alexandrescu V, Vincent G, Azdad K et al. A reliable approach to diabetic neuroischemic foot wounds: below-the-knee angiosome-oriented angioplasty. J Endovasc Ther 2011; 18: 376–87.
7. Iida O, Soga Y, Hirano K et al. Long-term results of direct and indirect endovascular revascularization based on the angio-some concept in patients with critical limb ischemia presenting with isolated below-the-knee lesions. J Vasc Surg 2012; 55: 363–70.
8. Balzer J, Khan V, Thalhammer A et al. Below the knee PTA in critical limb ischemia results after 12 months: single centre experience. Eur J Radiol 2010; 75: 37–42.
9. Falluji N, Mukherjee D. Contemporary management of infrapopliteal peripheral arterial disease. Angiology 2011; 62: 490–9.
10. Romiti M, Albers M, Brochado-Neto F et al. Meta-analysis of infrapopliteal angioplasty for chronic limb ischaemia. J Vasc Surg 2008; 47: 975–81.
11. Soderstrom M, Arvela E, Korhonen M et al. Infrapop-liteal percutaneous transluminal angioplasty versus bypass surgery as first-line strategies in critical leg ischemia. Ann Surg 2010; 252: 765–73.
12. Feiring A, Wesolowski A, Lade S. Primary stent-sup-ported angioplasty for treatment of below-knee critical limb ischemia and severe claudication: early and one-year outcomes. J Am Coll Cardiol 2004; 44: 2307–14.
13. Bosiers M, Lioupis C, Deloose K et al. Two-year outcome after Xpert stent implantation for treating below the knee lesions in critical limb ischemia. Vascular 2009; 17: 1–8.
14. Donas K, Torsello G, Schwindt A et al. Below knee bare nitinol stent placement in high risk patients with critical limb ischemia is still durable after 24 months of follow up. J Vasc Surg 2010; 52: 356–61.
15. Rand T, Lammer J, Rabbia C et al. Percutaneous trans-luminal angioplasty versus turbostatic carbon-coated stents in infrapopliteal arteries: In Peria II trial. Radiology 2011; 261: 634–42.
16. Biondi-Zoccai G, Sangiorgi G, Lotrionte M et al. In-fragenicular stent implantation for below-the-knee atherosclerotic disease: clinical evidence from an international collaborative meta-analysis on 640 patients. J Endovasc Ther 2009; 16: 251–60.
17. McKinsey J, Goldstein L, Khan H et al. Novel treatment of patients with lower extremity ischemia: use of percutaneous atherectomy in 579 lesions. Ann Surg 2008; 248: 519–28.
18. Zeller T, Sixt S, Schwarzwalder U et al. Two-year results after directional atherectomy of infrapopliteal arteries with the SilverHawk device. J Endovasc Ther 2007; 14: 232–40.
19. Zeller T, Krankenberg H, Steinkamp H et al. One-year outcome of percutaneous rotational atherectom­y with aspiration in infrainguinal peripheral arterial occlusive disease: the multi-center pathway PVD trial. J Endovasc Ther 2009; 16: 653–62.
20. Safian R, Niazi K, Runyon J et al. Orbital atherectomy for infrapopliteal disease: device concept and outcome data for the Oasis trial. Catheter Cardiovasc Interv 2009; 73: 406–12.
21. Laird J, Zeller T, Gray B et al. Limb salvage following laser-assisted angioplasty for critical limb ischemia: results of the LACI multicentre trial. J Endovasc Ther 2006; 13: 1–11.
22. Das T. Excimer laser-assisted angioplasty for infrainguinal artery disease. J Endovasc Ther 2009; 16 (Suppl. II): II98–II104.
23. Moussa I, Leon M, Baim D et al. Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy. Circulation 2004; 109: 2273–8.
24. Seabra-Gomes R. Percutaneous coronary interventions with drug eluting stents for diabetic patients. Heart 2006; 92: 410–9.
25. Scheinert D, Ulrich M, Scheinert S et al. Comparison of sirolimus-eluting versus bare-metal stents for the treatment of infrapopliteal obstruction. Eurointervention 2006; 2: 169–74.
26. Feiring A, Krahn R, Nelson L et al. Preventing leg amputations in critical limb ischaemia with below-the-knee drug-eluting stents. J Am Coll Cardiol 2010; 55: 1580–9.
27. Karnabatidis D, Spiliopoulos S, Diamantopoulos A. Primary everolimus-eluting stenting versus balloon angioplasty with bailout bare metal stenting of long infrapopliteal lesions for treatment of critical limb ischemia. J Endovasc Ther 2011; 18: 1–12.
28. Bosiers M, Scheinert D, Peeters P et al. Randomised comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease. J Vasc Surg 2012; 55: 390–8.
29. Rastan A, Tepe G, Krankenberg H et al. Sirolimus-eluting vs bare-metal stents for treatment of focal lesions in infrapopliteal arteries: a double-blind, multicenter, randomized clinical trial. Eur Heart J 2011; 32: 2274–81.
30. Tepe G, Scmehl J, Heller S et al. Drug eluting stents versus PTA with GP IIb/IIIa blockade below the knee in patients with current ulcers: the BELOW study. J Cardiovasc Surg 2010; 51: 203–12.
31. Martens J, Knippenberg B, Vos J et al. Update on PADI trial: percutaneous transluminal angioplasty and drug eluting stents for infrapopliteal lesions in critical limb ischemia. J Vasc Surg 2009; 50: 687–90.
32. Katsanos K, Siablis D, Zeller T et al. The ACHILLES study, a prospective, randomized, multicenter comparison of balloon angioplasty and CYPHER SEL ECT plus stent implantation. LINC-2011 (устная презентация).
33. Bosiers M. AMS INSIGHT Investigators AMS INSIGHT – absorbable metal stent implantation for treatment of below-the-knee critical limb ischemia: 6-month analysis. Cardiovasc Intervent Radiol 2009; 32: 424–35.
34. Schmidt A, Piorkowski M, Werner M et al. First experience with drug-eluting balloons in infrapopliteal arteries: reste-nosis rate and clinical outcome. J Am Coll Cardiol 2011; 58: 1105–9.
35. Liistro F, Angiolil P, Grottil S et al. Drug eluting balloon for below the knee angioplasty evaluation: the DEBATE BTK study. 2011; 
http://content.onlinejacc.org/cgi/reprint/58/20SupplS/B157.pdf
36. Mehta S, Yusuf S, Peters R et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001; 358 (9281): 527–33.
37. Brener S, Steinhubl S, Berger P et al. Dual antiplatelet therapy after percutaneous coronary intervention reduces ischemic events without affecting the need for repeat revascularization: insights fr om the CREDO trial. J Invasive Cardiol 2007; 19: 287–90.
38. Strobl F, Bantleon R, Brechtel K et al. Management of peripheral arterial interventions with mono or dual antiplatelet therapy: the MIRROR study. 2011;
http://spo.escardio.org/eslides/view.aspx?eevtid=48&fp=P5628
39. Iida O, Nanto S, Uematsu M et al. Cilostazol reduces restenosis after endovascular therapy in patients with femoro-popliteal lesions. J Vasc Surg 2008; 48: 144–9.
40. Wang J, Zhu Y, Li M et al. Batroxobin plus aspirin reduces restenosis after angioplasty for arterial occlusive disease in diabetic patients with lower-limb ischemia. J Vasc Interv Radiol 2011; 22: 987–94.

С.А.Терехин, В.Ю.Калашников

ФГБУ Эндокринологический научный центр Минздрава РФ, Москва